{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:58:29Z","timestamp":1767664709391,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":339,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007290","name":"Det Obelske Familiefond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1002\/rth2.12629","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T04:06:13Z","timestamp":1642046773000},"page":"e12629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8073-7664","authenticated-orcid":false,"given":"Anne Gulbech","family":"Ording","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flemming","family":"Skj\u00f8th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-0865","authenticated-orcid":false,"given":"Erik Lerkevang","family":"Grove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben Bjerregaard","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Br\u00f8nnum","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12629_bb0010","doi-asserted-by":"crossref","first-page":"E579","DOI":"10.1161\/CIR.0000000000000641","article-title":"Cardio\u2010oncology: vascular and metabolic perspectives: a scientific statement from the American Heart Association","volume":"139","author":"Campia","year":"2019","journal-title":"Circulation"},{"key":"10.1002\/rth2.12629_bb0015","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jacc.2019.01.017","article-title":"Anticoagulation strategies in patients with cancer: JACC review topic of the week","volume":"73","author":"Mosarla","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/rth2.12629_bb0020","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association practical guide on the use of non\u2010vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1002\/rth2.12629_bb0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"5","key":"10.1002\/rth2.12629_bb0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio\u2010Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1002\/rth2.12629_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ehjqcco\/qcy040","article-title":"Efficacy and safety of rivaroxaban vs. warfarin in patients with non\u2010valvular atrial fibrillation and a history of cancer: observations from ROCKET AF","volume":"5","author":"Chen","year":"2019","journal-title":"Eur Hear J Qual Care Clin Outcomes"},{"key":"10.1002\/rth2.12629_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008987","article-title":"Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the ENGAGE AF \u2010 TIMI 48 Trial","volume":"7","author":"Fanola","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1002\/rth2.12629_bb0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","article-title":"Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE trial","volume":"130","author":"Melloni","year":"2017","journal-title":"Am J Med"},{"key":"10.1002\/rth2.12629_bb0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2018.07.138","article-title":"Patients with cancer and atrial fibrillation treated with DOACs: a prospective cohort study","volume":"269","author":"Vedovati","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1002\/rth2.12629_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7150\/jca.36468","article-title":"Novel oral anticoagulant versus warfarin in cancer patients with atrial fibrillation: an 8\u2010year population\u2010based cohort study","volume":"11","author":"Wu","year":"2020","journal-title":"J Cancer"},{"key":"10.1002\/rth2.12629_bb0060","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cam4.1054","article-title":"Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population\u2010based cohort study","volume":"6","author":"Ording","year":"2017","journal-title":"Cancer Med"},{"key":"10.1002\/rth2.12629_bb0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.kint.2019.11.027","article-title":"Role of direct oral anticoagulants in patients with kidney disease","volume":"97","author":"Derebail","year":"2020","journal-title":"Kidney Int"},{"key":"10.1002\/rth2.12629_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2017.11.023","article-title":"Incidence of visible hematuria among antithrombotic agents: a systematic review of over 175,000 patients","volume":"114","author":"Bhatt","year":"2018","journal-title":"Urology"},{"key":"10.1002\/rth2.12629_bb0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.22465\/kjuo.2019.17.3.178","article-title":"A study on the efficacy and safety of rivaroxaban in urologic cancer\u2010associated venous thromboembolism","volume":"17","author":"Lee","year":"2019","journal-title":"Korean J Urol Oncol"},{"issue":"287","key":"10.1002\/rth2.12629_bb0080","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","article-title":"Epidemiology. When an entire country is a cohort","volume":"31","author":"Frank","year":"2000","journal-title":"Science"},{"key":"10.1002\/rth2.12629_bb0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1002\/rth2.12629_bb0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1002\/rth2.12629_bb0095","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"7 Suppl","key":"10.1002\/rth2.12629_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1002\/rth2.12629_bb0105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"4","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1002\/rth2.12629_bb0110","doi-asserted-by":"crossref","first-page":"f11","DOI":"10.1093\/ehjcvp\/pvab002","article-title":"Real\u2010world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta\u2010analysis of 605 771 patients","volume":"7","author":"Menichelli","year":"2021","journal-title":"Eur Hear J Cardiovasc Pharmacother"},{"key":"10.1002\/rth2.12629_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11239-020-02304-3","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta\u2010analysis","volume":"51","author":"Mariani","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1002\/rth2.12629_bb0120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4070\/kcj.2017.0328","article-title":"Effect of non\u2010Vitamin K antagonist oral anticoagulants in atrial fibrillation patients with newly diagnosed cancer","volume":"48","author":"Kim","year":"2018","journal-title":"Korean Circ J"},{"issue":"6","key":"10.1002\/rth2.12629_bb0125","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"18","author":"Sundboll","year":"2016","journal-title":"BMJ Open"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12629","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12629","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:22:51Z","timestamp":1762863771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922011025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2475037922011025"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12629","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}],"article-number":"e12629"}}